FILE:CAH/CAH-8K-20060511084048.txt.gz
EVENTS:	Regulation FD Disclosure	Financial Statements and Exhibits
TEXT:
ITEM: Regulation FD Disclosure
ITEM: Financial Statements and Exhibits
Table of Contents
 
 
     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (General Instruction A.2. below):
see
      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
o
 
 
Table of Contents
Item 7.01 Regulation FD Disclosure
     As previously announced, Jeffrey W. Henderson, Executive Vice President and Chief Financial Officer of Cardinal Health, Inc. (the "Company"), will address investors at Robert W. Baird & Co.'s 2006 Growth Stock Conference in Chicago on May 11, 2006 at 10:05 a.m. central time. Mr. Henderson will discuss the Company's diverse products and services, company performance and strategies for continued growth. His remarks will be webcast live. To access the webcast, go to the Investors page at http://www.cardinalhealth.com. An audio replay will be available until 11:00 p.m. on August 2, 2006 at http://www.cardinalhealth.com. A transcript will also be available at http://www.cardinalhealth.com. The Company is furnishing Mr. Henderson's slide presentation for the conference as Exhibit 99.01 to this report.
Item 9.01 Financial Statements and Exhibits
(c) Exhibits
     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Table of Contents

 
Exhibit 99.01
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 


